Robert Wills

Robert Wills serves as the Chairman of the Board at Milestone Pharmaceuticals, Inc. since September 2020, and holds board positions at Oncternal Therapeutics, Parion Sciences, GO Therapeutics, and Feldan Therapeutics. Previously, Robert Wills was Chairman of the Board at CymaBay Therapeutics and served as Executive Chairman at GTx, Inc. Additionally, Robert Wills was a member of the Emerging Companies Section Governing Board at the Biotechnology Innovation Organization. With a career spanning over two decades at Johnson & Johnson, Robert Wills held the position of Vice President of Alliance Management. Academic qualifications include a Doctor of Philosophy (Ph.D.) in Pharmacokinetics from The University of Texas at Austin and a Bachelor of Science (BS) in Biochemistry from the University of Wisconsin-Madison.